AbbVie is a leading global biopharmaceutical company dedicated to addressing the serious health needs of patients worldwide. With a focus on innovative treatments, AbbVie provides comprehensive information and resources regarding Central Precocious Puberty (CPP), a condition where children exhibit early signs of puberty before age 8 for girls and age 9 for boys. The brand offers guidance on recognizing the symptoms of CPP—including breast development, testicular enlargement, and pubic hair growth—and emphasizes the importance of consulting with a pediatrician for proper diagnosis and intervention.

AbbVie supports families with various resources, including treatment options and tools for assessing puberty development. Parents can access educational materials and FAQs, and locate specialized pediatric endocrinologists to ensure their child receives the appropriate care. Flourishing on a foundation of trust and timely action, AbbVie encourages caregivers to act on their instincts and seek expert medical advice to navigate the complexities of CPP effectively.